ATIC

Could screening change the future of type 1 diabetes?
By finding T1D before symptoms appear, screening can help identify people who may benefit from monitoring and treatments being studied to delay progression.
Screening for type 1 diabetes is available for all Australians over 1 year of age. Register now at type1screen.org

Screen today. Know more. Explore what’s possible.

We are looking for more people living with T1D to participate in this clinical trial! If you (or someone you know!) have type 1 diabetes and would like to contribute to advancing research in this space, please reach out via our website: atic.svi.edu.au or via email: [email protected]

Breaking News! The SAFEGUARD trial is now seeking children and teens (aged 5-17) who are newly diagnosed with type 1 diabetes to participate in a clinical trial that aims to protect the body's ability to make insulin!
We have clinical trial sites across Australia and New Zealand.
More information is available on our website: atic.svi.edu.au/clinical-trials or you can contact our friendly team via email [email protected]

Remember our BANDIT study? 💙
BANDIT showed that baricitinib, an immunotherapy drug, could help protect the insulin-producing beta cells in people recently diagnosed with type 1 diabetes. People who took baricitinib for 48 weeks were able to keep producing more of their own insulin and needed less injected insulin than those who received placebo. This new follow-up study asked an important question: what happens after treatment stops?
You can read more here:

Further Results From The BANDIT Study | ATIC Further results from the BANDIT study have been published in Diabetes Care.

Are you an adult living with type 1 diabetes who is interested in taking part in the research of a new treatment?
The MT101-101 study is now available in Melbourne, Brisbane and the Gold Coast. There are more details available on the ATIC website (atic.svi.edu.au/clinical-trials/) or contact us using the details in the image. Our friendly team look forward to hearing from you. 😊

Team ATIC are looking forward to being at the IDF-WPR/ADC 2026 combined congress next week in Melbourne. We will be exhibiting in the Breakthrough T1D Australia booth (booth 112) and we are looking forward to a week of learning, sharing and collaborating. We're excited to meet those of you that will be there too - please come and say hello!

The SAFEGUARD study is now available for 12-17 year olds in Australia and New Zealand!
If you know a child or teen who has been diagnosed with type 1 diabetes in the last 100 days, they might be interested in being involved in a clinical trial of a new medicine that is hoped to protect the body's ability to make insulin, please visit our website for more information or to register your interest at atic.svi.edu.au/clinical-trials

Reminder! Prof Simon Barry will be presenting the Beyond Insulin seminar tomorrow. Registration details are in the post below. Look forward to seeing you there.

Using Immunogenomics To Unravel The Drivers Of Progression In T1D: The Path To Prevention And Cure? Seminar 33, Beyond Insulin Seminar Series - Professor Simon Barry presents Using Immunogenomics to unravel the drivers of progression in T1D: the path to prevention and cure?

The MT101-101 study is now available in Victoria and Queensland. If you are an adult with type 1 diabetes and you are interested in taking part in research for a new therapy, please visit our website (atic.svi.edu.au/clinical-trials/) or contact us using the details in the image.